Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 7 January 2026

Ventyx stock jumps on Lilly’s $1.2 billion buyout — and why it’s still trading under $14

Ventyx stock jumps on Lilly’s $1.2 billion buyout — and why it’s still trading under $14

Eli Lilly agreed to acquire Ventyx Biosciences for $14 per share in cash, valuing the company at about $1.2 billion. Ventyx shares closed up 37% at $13.81, while Lilly rose 4%. The deal is expected to close in the first half of 2026, pending shareholder approval. Investors await proxy filings and Lilly’s next earnings call for further details.
7 January 2026
···
Dow Jones falls from intraday record as Trump policy moves hit financials; jobs report next

Dow Jones falls from intraday record as Trump policy moves hit financials; jobs report next

The Dow Jones fell 0.94% to 48,996.08 after Trump proposed banning Wall Street from buying single-family homes and restricting defense contractor payouts, sending financial and defense stocks lower. JPMorgan dropped 2.3% after a downgrade. Nvidia and Alphabet gains lifted the Nasdaq 0.16%. Investors await Friday’s U.S. payrolls report for rate signals.
7 January 2026
······
Goldman Sachs stock falls after Apple Card handoff report — here’s what investors watch next

Goldman Sachs stock falls after Apple Card handoff report — here’s what investors watch next

Goldman Sachs shares dropped 1.7% after hours to $941.02 following a Wall Street Journal report that JPMorgan Chase will take over the $20 billion Apple Card portfolio. Goldman is expected to sell the balances at a discount exceeding $1 billion. Investors are watching for details on consumer-exit costs when Goldman reports fourth-quarter results on Jan. 15.
7 January 2026
····
AST SpaceMobile (ASTS) stock sinks 12% after Scotiabank downgrade calls valuation ‘irrational’

AST SpaceMobile (ASTS) stock sinks 12% after Scotiabank downgrade calls valuation ‘irrational’

AST SpaceMobile shares dropped 12.1% to $85.73 after Scotiabank downgraded the stock to sector underperform and set a $45.60 target, citing high valuation and the need to build out its satellite network. The stock had surged 324% over the past year. AST aims to launch 45–60 satellites by end-2026 but has no retail customers yet. Investors await updates on launch schedules and the next earnings report.
7 January 2026
·
UnitedHealth stock drops after-hours as Optum UK sale talk swirls ahead of Jan. 27 earnings

UnitedHealth stock drops after-hours as Optum UK sale talk swirls ahead of Jan. 27 earnings

UnitedHealth Group shares fell 2% to $341.70 in after-hours trading Wednesday, following a late-session slide. The drop came as investors weighed a possible Optum UK sale to TPG for up to $1.89 billion and awaited the company’s Jan. 27 earnings report. Peers Cigna, CVS Health, and Elevance Health also declined. U.S. job openings hit a 14-month low, further pressuring market sentiment.
7 January 2026
··
Boeing stock slips after-hours despite Alaska Airlines’ record jet order, with earnings next on Jan. 27

Boeing stock slips after-hours despite Alaska Airlines’ record jet order, with earnings next on Jan. 27

Boeing shares fell 0.7% in after-hours trading to $228.12 after Alaska Airlines announced an order for 110 jets, mostly 737-10s. The 737-10 still awaits FAA certification, raising questions about delivery timelines. Alaska’s order includes 105 737-10s and five 787s, with options for 35 more jets. Investors are watching for regulatory updates and Boeing’s Jan. 27 earnings report.
7 January 2026
··
Lockheed Martin stock slides after Patriot missile deal, Goldman sticks to $430 sell target

Lockheed Martin stock slides after Patriot missile deal, Goldman sticks to $430 sell target

Lockheed Martin signed a seven-year deal with the U.S. Department of War to boost annual PAC-3 missile production from about 600 to 2,000 units. The company delivered a record 620 missiles in 2025 and expects the new program to add thousands of jobs. Lockheed shares fell 4.8% Wednesday, while President Trump threatened to block defense contractor dividends and buybacks unless production speeds up.
7 January 2026
··
Netflix stock steadies after Warner board rejects Paramount bid again, earnings next

Netflix stock steadies after Warner board rejects Paramount bid again, earnings next

Netflix shares rose 0.1% to $90.73 after hours Wednesday as Warner Bros. Discovery urged shareholders to reject Paramount Skydance’s revised offer and stick with Netflix’s merger deal. Warner’s board called Paramount’s bid risky and debt-heavy. Paramount Skydance shares fell 1.1%. Warner shareholders have until Jan. 21 to tender shares into Paramount’s offer.
7 January 2026
····
Sandisk Corporation stock steadies after CES-fueled spike as Jan. 29 earnings loom

Sandisk Corporation stock steadies after CES-fueled spike as Jan. 29 earnings loom

Sandisk shares climbed 1.2% to $353.56 in after-hours trading Wednesday, outperforming Western Digital and Seagate, which fell sharply. The stock extended gains after Nvidia CEO Jensen Huang’s CES remarks on new storage technology. Investors await Sandisk’s Jan. 29 results for updates on NAND pricing and AI demand. Sandisk completed its split from Western Digital in February 2025.
7 January 2026
···
Eli Lilly stock jumps after $1.2B Ventyx buy as obesity-pill bets come into focus

Eli Lilly stock jumps after $1.2B Ventyx buy as obesity-pill bets come into focus

Eli Lilly shares rose 4.1% to $1,108.09 after the company agreed to acquire Ventyx Biosciences for $1.2 billion in cash. Ventyx holders will receive $14 per share, a 62% premium to its 30-day VWAP. The deal is expected to close in the first half of 2026, pending regulatory and shareholder approval. Lilly also announced a multi-year obesity drug partnership with Nimbus Therapeutics.
7 January 2026
···
Rocket Lab stock slips after COO’s $7.3 million sale filing; RKLB focus shifts to earnings

Rocket Lab stock slips after COO’s $7.3 million sale filing; RKLB focus shifts to earnings

Rocket Lab shares closed down 2.2% at $84.16 after an SEC filing showed COO Frank Klein sold 100,000 shares under a pre-set plan for about $7.3 million. The stock had swung between $81.85 and $85.96 during the session. Investors are watching for the company’s next earnings report on Feb. 26 and updates on its Neutron rocket timeline.
7 January 2026
···
Strategy Inc stock rises after MSCI drops plan to kick bitcoin-treasury firms out of indexes

Strategy Inc stock rises after MSCI drops plan to kick bitcoin-treasury firms out of indexes

MSCI dropped plans to exclude digital-asset treasury firms from its equity indexes and will conduct a broader review. Strategy (MSTR.O) rose 2.5% after hours to $161.83, despite bitcoin falling 2.7% to $90,986. A recent SEC filing showed Strategy bought 1,283 bitcoin for $116 million and reported a $17.44 billion unrealized quarterly loss on crypto holdings.
7 January 2026
···
AMD stock slips after hours as CES AI chip blitz sets up Feb. 3 earnings test

AMD stock slips after hours as CES AI chip blitz sets up Feb. 3 earnings test

AMD shares fell about 2% to $210.02 in after-hours trading Wednesday, following a weaker chip sector. The drop comes after CEO Lisa Su unveiled new AI chips and processors at CES in Las Vegas. Investors await AMD’s Q4 and full-year results on Feb. 3 and U.S. payrolls data on Friday. The Philadelphia Semiconductor Index closed down about 1%.
7 January 2026
···
Meta stock drops after hours as court fight and smart-glasses supply squeeze keep traders cautious

Meta stock drops after hours as court fight and smart-glasses supply squeeze keep traders cautious

Meta Platforms shares dropped 1.8% to $648.69 in after-hours trading Wednesday amid investor rotation in big tech. The company paused international expansion of its Ray-Ban Display smart glasses due to U.S. demand and supply limits. Mark Zuckerberg named C.J. Mahoney as chief legal officer, replacing Jennifer Newstead, who will join Apple. U.S. job openings fell in November, while private payroll growth lagged forecasts.
7 January 2026
·
1 … 438 439 440 441 442 … 1,170

Stock Market Today

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
New York, Feb 7, 2026, 11:29 ET — Market closed. AbbVie shares closed up 2% on Friday at $223.43, extending a second straight session of gains as U.S. stocks rallied. The stock is still roughly 9% below its 52-week high, and trading volume ran a bit under its recent average. (MarketWatch) The bounce comes as investors work through AbbVie’s post-earnings reset and what it means for 2026. The drugmaker said fourth-quarter net revenues rose 10% to $16.618 billion and adjusted profit per share—excluding certain items—was $2.71; it forecast 2026 adjusted earnings of $14.37 to $14.57 a share. Chief Executive Robert
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
Go toTop